CHIMIA 12/2014, Vol. 68

 

Life Science START-UPS in Switzerland
2014 12

 

external link Scientific Content/Articles


All articles of this issue are available on

Logo IngentaConnect

To access the articles you must be a SCS member or a CHIMIA subscriber.

 

 

  

Additional content

Venture Capital Investments for Life Sciences Start-ups in SwitzerlandP. Gantenbein*, N. Herold

Editorial 833 Icon FreeContent

Contents 834 Icon FreeContent

Scientific Content 836 Icon OpenAccessContent

Icon ExternalLinkVenture Capital Investments for Life Sciences Start-ups in Switzerland
P. Gantenbein*, N. Herold

  840 Icon OpenAccessContent Icon ExternalLinkBeyond Borders 2014 – Overview of the Biotechnology Landscape
J. Zürcher
  844 Icon OpenAccessContent Icon ExternalLinkBusiness Angels – A Subspecies of the homo oeconomicus ludens
L. Hüsler, E. M. Platzer*
  847 Icon OpenAccessContent Icon ExternalLinkVenture Capital Investment in the Life Sciences in Switzerland
M. Hosang
  850 Icon OpenAccessContent Icon ExternalLinkLegal Challenges and Pitfalls for Start-up Companies – 48 Common Questions and Answers
M. Staehelin
  855 Icon OpenAccessContent Icon ExternalLinkA Strong Start-up Scene Flourishes in the Life Sciences Capital Basel
P. Burckhardt
  858 Icon OpenAccessContent Icon ExternalLinkThe Greater Zurich Area is Well-positioned in the Life Sciences in Switzerland and Europe
M. Jenni
  863 Icon OpenAccessContent Icon ExternalLinkThe Health Valley: Global Entrepreneurial Dynamics
B. Dubuis
  869 Icon OpenAccessContent Icon ExternalLinkLife Sciences in the Ticino: Two Scientists – Two Stories
Interview partners: Luca Varani, Marco Brini S. Lauber Fürst
  871 Icon OpenAccessContent Icon ExternalLinkLife Science Start-up Activities at the Universities of Applied Sciences (UAS)
G. Huber
  874 Icon OpenAccessContent Icon ExternalLinkCommercializing Academic Research Results and the Role of Spin-off Companies
H. Reutimann
  876 Icon OpenAccessContent Icon ExternalLinkLife Sciences Start-ups in Switzerland: CTI and its Support for Young Entrepreneurs
K. Sekanina
  879 Icon OpenAccessContent Icon ExternalLinkInnovate with the CTI National Thematic Networks
S. Lauber Fürst
  882 Icon OpenAccessContent Icon ExternalLinkFoundations as Promoters of Life Science Start-ups
P. Vonmont
  885 Icon OpenAccessContent Icon ExternalLink>>venture>>: Support for Early Stage Start-ups and Potential Entrepreneurs
L. Kauz, Communication >>venture>>
  887 Icon OpenAccessContent Icon ExternalLinkSeed Capital for Young Entrepreneurs since more than 25 Years
J.-P. Vuilleumier
  888 Icon OpenAccessContent Icon ExternalLinkBioVersys Works to Bring Antibiotic Resistance to an End
M. Tigges*, M. Gitzinger*
  891 Icon OpenAccessContent

Icon ExternalLinkBig Hopes with Small Molecules – PIQUR Therapeutics AG is aiming to Turn Cancer into a Manageable Disease
PIQUR Therapeutics AG

Conference Report 893 Icon FreeContent

Columns   896 Icon FreeContent
899 Icon FreeContent
900 Icon FreeContent
SCG/SCS/SSC 901 Icon FreeContent
Information 905 Icon FreeContent

Diverses 907 Icon FreeContent

CHIMIA-Report 908 Icon FreeContent

Index   Icon FreeContent

Icon FreeContent Free Content
Icon OpenAccessContent Open Access Content
Icon SubscribedContent Subscribed Content. To access the articles you must be a SCS member or a CHIMIA subscriber.

TPL_BEEZ2_ADDITIONAL_INFORMATION